DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Umpierrez GE, Blevins T, Rosenstock J et al.
The effects of LY2189265, a long-acting glucagon-like peptide-1 analogue, in a randomized, placebo-controlled, double-blind study of overweight/obese patients with type 2 diabetes: the EGO study.
Diabetes Obes Metab 2011;
13: 418-425
Access:
We do not assume any responsibility for the contents of the web pages of other providers.